Cancer sucks. Everyone knows someone who has been affected by this deadly disease. And while treatment has come a long way, there is still no cure. The disease kills more than 600,000 people in the United States every year. Billions of dollars have been poured into cancer drug development for decades… but to no avail.  Oncolyze, the anti-cancer biotech startup I’m introducing to you today, has some of the most promising efficacy data that…